ARK Genomic Revolution Multi-Sector ETF (ARKG) ETF

Expense Ratio: 0.75% | AUM: 1.36B | Issuer: Ark Funds

ARKG Daily Price Range
ARKG 52-Week Price Range

ARKG - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

ARKG has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

ARKG - Profile & Info


The investment objective of the ARK Genomic Revolution Multi-Sector ETF seeks to invest in companies substantially focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business. One such way this is accomplished is by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may develop, produce or enable: Agricultural Biology, Bioinformatics, Bionic Medicine, DNA Sequencing, Instrumentation, Stem Cells, Pharmaceutical Innovation, Molecular Medicine and Diagnostics, and Bio-inspired Computing. The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health-care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.

Issuer Ark Funds
Expense Ratio 0.75%
Assets Under Management (AUM) 1.36B
Asset Class Portfolio-Multi Asset
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $53.15
Options? Yes
Total Holdings 34

ARKG - Top Holdings

Symbol Holding Name % of Total
CRSP CRISPR Therapeutics AG 9.33%
NVTA Invitae Corp 8.54%
ILMN ILLUMINA INC 8.31%
CGEN Compugen Ltd 7.32%
ARCT:US ARCTURUS THERAPEUTICS HOLDIN 6.38%
NTLA Intellia Therapeutics Inc 5.13%
IOVA Iovance Biotherapeutics Inc 4.08%
EDIT EDITAS MEDICIN 3.66%
CDNA CareDx Inc 3.54%
CLLS CELLECTIS - ADR 3.33%
TWST Twist Bioscience Corp 3.11%
CERS CERUS CORP 3.01%
GH Guardant Health 2.69%
VCYT Veracyte Inc 2.67%
PACB Pacific Biosciences of California Inc 2.50%
INCY INCYTE CORP 2.39%
SYRS Syros Pharmaceuticals Inc 2.28%
PSTG Pure Storage Inc 2.27%
FATE FATE THERAPEUTIC 2.23%
TXG 10X GENOMICS 2.13%
PSNL PERSONALIS INC 1.91%
CDXS Codexis Inc 1.60%
NSTG NanoString Technologies Inc 1.56%
CSTL Castle Biosciences Inc 1.45%
IONS Ionis Pharmaceuticals 1.45%
MCRB Seres Therapeutics Inc 1.39%
ADPT Adaptive Biotechnologies 1.03%
INO Inovio Pharmaceuticals Inc 0.92%
TDOC TELADOC HEALTH 0.79%
PSTI Pluristem Therapeutics Inc 0.73%
CBMG CELLULAR BIOMEDICINE GROUP I 0.69%
SDGR SCHRODINGER INC 0.61%
ONVO Organovo Holdings Inc 0.50%
ARKG ARK Genomic Revolution Multi-Sector ETF 0.00%

ARKG - Price/Volume Stats

Current price $54.06
Prev. close $53.19
Day low $53.38
Day high $54.75
52-week high $54.75
52-week low $24.00
Day Volume 571,667
Avg. volume 392,393
Dividend yield 3.97%

ARKG - Recent Returns

1-mo 20.47%
3-mo 71.73%
6-mo 59.80%
1-year 66.97%
3-year 161.63%
5-year 159.64%
YTD 61.28%
2019 48.47%
2018 -0.95%
2017 44.65%
2016 -19.23%
2015 -1.27%

ARKG - Stock Chart


ARKG - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 1.3549 seconds.